Benzinga | Nov 5, 2021 09:28AM EDT

NGM Biopharmaceuticals Q3 EPS $(0.37) Up From $(0.43) YoY, Sales $18.57M Down From $23.48M YoY

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.37) per share. This is a 13.95 percent increase over losses of $(0.43) per share from the same period last year. The company reported $18.57 million in sales this quarter. This is a 20.90 percent decrease over sales of $23.48 million the same period last year.